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Depressive symptoms are associated with cognitive-functional impairment in normal
aging older adults (NA). However, less is known about this effect on people
with mild Cognitive Impairment (MCI) and mild Alzheimer’s disease dementia
(AD). We investigated this relationship along with the NA-MCI-AD continuum by
reanalyzing a previously published dataset. Participants (N = 274) underwent
comprehensive neuropsychological assessment including measures of Executive
Function, Language/Semantic Memory, Episodic Memory, Visuospatial Abilities,
Activities of Daily Living (ADL), and the Geriatric Depression Scale. MANOVA,
logistic regression and chi-square tests were performed to assess the association
between depression and cognitive-functional performance in each group. In the NA
group, depressed participants had a lower performance compared to non-depressed
participants in all cognitive and functional domains. However, the same pattern was not
observed in the MCI group or in AD. The results suggest a progressive loss of association
between depression and worse cognitive-functional performance along the NA-MCI-AD
continuum.
Keywords: older adults, depression, cognitive assessment, activities of daily living, neuropsychological
assessment, mild cognitive impairment, Alzheimer’s disease
INTRODUCTION
Depressive symptoms and cognitive impairment are common in older adults and often coexist in
an individual patient. The pattern of cognitive impairment associated with depressive symptoms
involves executive dysfunction, reduced processing speed, and deficits in episodic memory (Butters
et al., 2004; Sexton et al., 2012; de Paula et al., 2013a), while global intellectual ability, language
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skills, visuospatial abilities, and semantic processing are usually
spared (Naismith et al., 2003). Furthermore, late-life depression
is a risk factor for cognitive decline and dementia, in particular
Alzheimer’s disease dementia (AD) and vascular dementia (Diniz
et al., 2013).
The neurobiological mechanisms connecting the depressive
symptoms with cognitive and functional performance are
heterogeneous. Naismith et al. (2012) reviewed evidences from
different types of studies, which discussed changes inmonoamine
systems dysfunction, hormonal and immunologic changes,
inflammatory processes, and alterations on genes expression.
These different mechanisms may increase neurodegenerative
and vascular factors, which may mediate the cognitive and
functional changes associated with depression (Butters et al.,
2008). However, as reviewed by Panza et al. (2010), there
is an important overlap between depression, mild cognitive
impairment (MCI) and dementia: depression may overlap with
clinical MCI, may be a reaction to the initial symptoms of MCI,
may be one of the behavioral manifestations of MCI, or may
mask a clinical MCI. As reviewed by the authors, differences in
the studies settings and design, participants’ characteristics, and
the procedures to diagnose depression and MCI may contribute
to the inconsistency found among the studies, including the
prevalence of these conditions, its cognitive features and risk of
conversion to dementia.
Despite the well-documented impact of depressive symptoms
on cognition, the relationship of symptoms’ intensity and
cognitive performance on older adults with neurocognitive
disorders, in particular MCI and AD, is controversial. Previous
studies found no association between depressive symptoms and
neuropsychological performance in mild AD or MCI patients.
Bangen et al. (2010) assessed depressed and non-depressed AD
patients with a comprehensive neuropsychological battery and
found no differences on the cognitive performance of these
participants. On the other hand, AD patients with depression
showed a greater impairment in attention and executive function
tests when compared to non-depressed AD patients in another
study (Nakaaki et al., 2007). A recent study showed that
depressive symptoms are related to the cognitive decline in AD,
even after controlling for baseline cognitive status (Zahodne
et al., 2013). The controversy occurs on the relationship between
depression and functional performance. Depressive symptoms
are associated with poorer performance on activities of daily
living (ADL) in community-dwelling and institutionalized older
adults (Nyunt et al., 2012; Tomita and Burns, 2013; de Paula
et al., 2015a), and are important predictors of functional status
in MCI subjects (Bombin et al., 2012). The presence of cognitive
impairment and comorbid depressive symptoms seems to lead
to worse functional outcomes (Wadsworth et al., 2012). On the
other hand, different studies did not find a significant association
between depressive symptoms and functional status along the
normal aging (NA)—MCI—AD continuum (Reppermund et al.,
2011).
Altogether, these results suggest that depressive symptoms
may have a distinct impact on cognitive and functional
performance in normal aging, MCI and AD. In this sense, the
aim of the present study is to evaluate how depressive symptoms
moderate the cognitive and functional performance along this
continuum. We have reanalyzed a dataset used in previous
studies (de Paula et al., 2013b, 2014, 2015a).
MATERIALS AND METHODS
Participants
We included 274 older adults in the present study from a
convenience sample. This study was approved by the local
ethics board (registry 334/06). All subjects gave written informed
consent for participation. The caregivers of dementia patients
had also filled the consent form. The study is in accordance with
the Declaration of Helsinki. These participants and their data
were described in previously published studies (de Paula et al.,
2013b, 2014, 2015a). Participants were evaluated at the outpatient
geriatric clinic in the Federal University of Minas Gerais, Brazil.
Patients which in primary-care medical assessment had memory
complains or voluntarily asked for a cognitive assessment
were referred for the outpatient clinic, where a comprehensive
assessment was performed and they were subsequently invited
for participation. Most of these patients has a very low formal
education (below 5 years) and low socioeconomic status.
Figure 1 shows the methods used for patient’s diagnoses
and the methods used for this research. The Brazilian version
of the Mattis Dementia Rating Scale (Porto et al., 2003), the
Mini-Mental State Examination (MMSE; Folstein et al., 2001),
subtests of the CERAD Neuropsychological Battery (Morris
et al., 1989), and the Clinical Dementia Rating (CDR; Morris,
1993) were adopted. CDR scores below 1 are not indicative of
dementia, while those equal or above this value are indicative
of mild (1), moderate (2), or severe (3) dementia (Morris,
1993). Only participants with CDR scores equal or below 1 were
included. The performance on cognitive tests was adjusted for
age and educational status, based on Brazilian norms, and were
previously validated for the diagnosis of mild AD and MCI
(Brucki et al., 2003; Porto et al., 2003; Nitrini et al., 2004; Foss
et al., 2013; Table 1 shows the participants sociodemographic
characteristics, performance in cognitive tests used for diagnosis
and the median for each test based in normative data).
Cognitive status was adjudicated in expert multidisciplinary
meetings taking into account clinical, cognitive assessment,
laboratorial, and neuroimaging data when available. We
performed the diagnosis of probable AD according to the
NINCDS-ADRDA criteria (McKhann et al., 1984). It involved
cognitive impairment objectively assessed by neuropsychological
tests of episodic memory and at least on other cognitive
domain (Executive Functions, Visuospatial Abilities, and
Language/Semantic Memory) from subtests of the Brazilian
versions of the CERAD Neuropsychological Battery and the
Mattis Dementia Rating Scale; functional impairment when
compared to a previous level of performance (assessed by the
functional components of the CDR and by a clinical interview
conducted by an experienced geriatrician); insidious onset;
clear-cut report of cognitive/functional decline; and no evidence
of major neurologic or psychiatric conditions which could
respond for the symptom.
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Protocol adopted for diagnosis Protocol adopted for research 
FIGURE 1 | Description of the protocol used for participant’s diagnosis/classification, and procedures adopted for this study. Participants initially
underwent a medical and neuropsychological assessment for diagnostic procedures. In all, 274 older adults were divided into Normal Aging (NA, N = 96), mild
cognitive impairment (MCI, N = 85), mild dementia, and Alzheimer’s disease dementia (AD, N = 93). After diagnosis, they performed the procedures of the study,
involving the assessment of cognitive functioning, depression and activities of daily living.
The diagnosis of MCI was done according to the following
criteria, adapted from Petersen et al. (2001): (1) subjective
cognitive complaint, preferably corroborated by an informant;
(2) objective impairment in the performance on specific
cognitive tests of the assessment battery (verbal learning test
from the CERAD battery and subscales from the Mattis
Dementia Rating Scale); (3) preserved global cognitive
functioning [MMSE above the cut-off for dementia adjusted
for education (as in Brucki et al., 2003), and CDR<1];
(4) preserved or minimal impairments in ADL assessed
by a clinical interview and the functional components of
the CDR; (5) not demented. The MCI patients included
on the study has symptoms and progression characteristic
of Alzheimer’s disease (amnestic presentation—deficits in
learning and recall of new information, insidious onset,
and clear-cut history of worsening of cognition by caregiver
report).
We also assessed older adults with no evidence of cognitive
impairment in the screening protocol to form a control group
without clinical history suggestive of Alzheimer’s disease. These
participants composed the normal aging group (NA). We invited
them for participation in the same institution where we assessed
the MCI and AD participants. They do not show a CDR
suggestive of dementia (CDR<1) and has cognitive tests above
the cut-off values for cognitive impairment. Participants with
subjective cognitive complaints did not have a symptomatology
or clinical course suggestive of Alzheimer’s disease (as cited in AD
and MCI participant’s description). These participants have none
or discrete functional impairment assessed in a clinical interview,
no history of neurological diseases and no sensorial or motor
impairment, which may compromise the neuropsychological
assessment.
Our final sample consisted of 274 participants: 62 NA non-
depressed, 34 NA depressed 63 MCI non-depressed, 22 MCI
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TABLE 1 | Participant’s description in sociodemographic and cognitive measures used for diagnosis.
Measures Normative dataa NA MCI AD
(median) M SD M SD M SD
Sociodemographic Age – 72.61 7.76 73.18 8.46 74.57 6.65
Education – 5.22 4.29 4.71 4.00 4.82 3.46
Global measures MMSE 26 25.75 3.85 23.52 3.62 20.59 3.98
DRS—Total 129 128.02 9.24 114.56 12.93 97.36 12.20
Attention DRS—Attention 35 35.34 1.41 34.71 1.75 33.61 2.17
Executive functions DRS—Initiative/Perseveration 33 32.92 4.46 28.32 5.66 22.82 5.40
Visuospatial abilities DRS—Construction 6 5.42 1.13 5.25 3.50 4.14 1.89
Language DRS—Conceptualization 32 32.26 4.92 28.48 6.46 24.23 5.26
Memory DRS—Memory 23 22.04 2.44 18.06 3.77 12.55 3.99
CERAD-VL (Total) 18 16.58 2.3 12.87 2.14 10.44 2.15
CERAD-VL (Recall) 5 5.49 1.83 2.18 1.63 2.11 1.79
CERAD-VL (Recognition) 9 8.89 1.41 6.69 1.69 3.44 2.17
NA, Normal Aging; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease dementia; MMSE, Mini-Mental State Examination; DRS, Mattis Dementia Rating Scale; CERAD-VL, Verbal
Learning Test from The Consortium to Establish a Registry for Alzheimer’s disease neuropsychological battery.
aBased in Brazilian normative/adaptation studies with older adults with similar age (±75 years) and education (±4 years).
depressed, 66 AD non-depressed, and 27 AD depressed. We
described these previous in previously published studies (de
Paula et al., 2013b, 2014, 2015a).
Assessment of Depressive Symptoms
We evaluated the presence of depression by the Brazilian
version of the Geriatric Depression Scale-15 (GDS-15; Sheikh
and Yeasavage, 1986). The cut-off score 5/6 (non-case/case)
was chosen to determine the presence of clinically significant
depressive. We adopted this cut-off due to its good validity for
detection of significant depressive symptoms in our population,
which includes patients with low socioeconomic status, low
formal education, and cognitive complaints (Almeida and
Almeida, 1999). A validation study propose this cut-off for the
detection of depression according to the DSM-IV and ICD-10
criteria (Almeida and Almeida, 1999).
The use of the GDS for the detection of depressive symptoms
and diagnosis of a depressive episode in AD patients is
controversial. Some studies report a loss of validity in patients
with dementia (Feher et al., 1992), while others do not (Brown
et al., 2007). The previous reports suggests that patients
in moderate or severe dementia may not report depressive
symptoms accurately. To reduce these biases we selected only
patients with mild dementia for the AD group (CDR≤1). Due
to participant’s low formal education, to ensure the questions
comprehension and validity of the report the examiner read
the questions aloud. The diagnosis of AD, MCI or NA, was
irrespective of the GDS-15 scores.
Neuropsychological Assessment
(Research Protocol)
All participants underwent a comprehensive neuropsychological
assessment protocol focused on the assessment of executive
functions, memory, language, and visuospatial cognitive
domains. The protocol was designed for the assessment of
older adults with low formal education level. We detailed these
procedures in a previous study conducted in this sample (de
Paula et al., 2013b). We have not used these neuropsychological
tests were for diagnostic purpose, and they were administered by
trained neuropsychologists.
The battery is comprised by the following tests: Digit Span
Forward and Backward (Kessels et al., 2008), verbal fluency
“fruits,” “animals,” and letter (“S”) (de Paula et al., 2013b), and
the Frontal Assessment Battery (Dubois et al., 2000) [Factor
Executive Functions]; the three components of the Laboratory of
Neuropsychological Investigations Naming Test (Malloy-Diniz
et al., 2007a) [Factor Language/Semantic Memory]; the Brazilian
Portuguese Rey Auditory-Verbal Learning Test (Malloy-Diniz
et al., 2007b) [Factor Episodic Memory]; Token Test components
of attention and comprehension (De Renzi and Faglioni, 1978;
de Paula et al., 2013b), the Clock Drawing Test (Shulman,
2000); and the Stick Design Test (Baiyewu et al., 2004)
[Factor Visuospatial Abilities]. Supplementary Table 1 shows the
participant’s performance in each neuropsychological measures,
its clinical cut-offs and maximum possible score. Supplementary
Table 2 shows the factor analysis.
Activities of Daily Living Assessment
Participant’s caregivers (usually spouses or other relatives)
answered an adapted Activities of Daily Living Scale (ADL)
based on the Lawton and Brody (1969), and Katz et al. (1970)
indexes of ADL. The scale assess 13 basic and instrumental
activities (de Paula et al., 2014). The scale consists of three ADL
aspects: Self-Care (Basic ADL), Domestic (Instrumental ADL
performed at home), and Complex (Instrumental ADL involving
activities outside home, financial management and medication
control). Scores on Basic ADL range from 0 to 10, and 0 to
8 on Domestic or Complex ADL; with lower scores indicating
greater impairment. Due to data distribution, we categorized the
functional performance (impairment × no-impairment) based
in dependence of human help (full or partial) to perform at
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TABLE 2 | Participant’s scores in GDS-15 and performance in the neuropsychological factors obtained by factor analysis of the research protocol
stratified by group and depression.
Group Depression Statistic GDS-15 Language
semantic
Episodic
memory
Visuospatial
abilities
Executive
functions
G-ADL
self-
care
G-ADL
domestic
G-ADL
complex
G-ADL
general
Normal
aging
(N = 96)
Non-depressed
(N = 62)
M 1.81 0.00 0.00 0.00 0.00 9.92 7.92 7.85 25.69
SD 1.30 1.00 1.00 1.00 1.00 0.38 0.33 0.51 0.93
Min-Max 0 to 5 −3.54 to
1.39
−1.60 to
1.14
−2.62 to
1.70
−2.70 to
1.63
8 to 10 6 to 8 5 to 8 20 to 26
Depressed
(N = 34)
M 8.94 −0.99 −0.79 −0.87 −1.63 9.97 7.24 7.00 24.21
SD 2.80 1.26 0.77 0.99 1.25 0.17 1.28 1.92 3.02
Min-Max 6 to 15 −3.54 to
1.13
−2.72 to
0.86
−2.46 to
1.12
−5.80 to
0.90
9 to 10 4 to 8 1 to 8 15 to 26
Mild
cognitive
impairment
(N = 85)
Non-depressed
(N = 63)
M 2.06 −0.75 −1.30 −0.87 −1.19 10.00 7.41 6.94 24.35
SD 1.50 1.05 0.73 1.09 1.05 0.00 1.25 1.45 2.28
Min-Max 0 to 5 −3.52 to
1.05
−2.74 to
0.70
−2.70 to
2.07
−3.70 to
1.00
10 to 10 2 to 8 2 to 8 16 to 26
Depressed
(N = 22)
M 5.45 −0.76 −1.01 −0.76 −1.28 9.95 7.41 6.82 24.18
SD 4.08 0.67 0.66 0.90 1.09 0.21 1.05 1.56 2.56
Min-Max 6 to 13 −2.05 to
0.40
−2.19 to
0.35
−2.34 to
0.80
−3.30 to
0.30
9 to 10 5 to 8 3 to 8 18 to 26
Mild
Alzheimer’s
dementia
(N = 93)
Non-depressed
(N = 66)
M 2.05 −1.74 −1.81 −1.62 −2.44 9.86 5.76 4.53 20.15
SD 1.39 1.22 0.64 1.06 1.04 0.52 2.11 2.53 4.00
Min-Max 0 to 5 −3.54 to
0.78
−2.78 to
0.39
−2.70 to
2.58
−5.20 to
0.40
7 to 10 0 to 8 0 to 8 10 to 26
Depressed
(N = 27)
M 8.19 −1.55 −1.64 −1.12 −1.79 9.59 5.70 3.93 19.22
SD 2.04 1.01 0.66 0.94 1.09 1.39 2.40 2.67 5.49
Min-Max 6 to 14 −2.85 to
0.40
−3.00 to
0.00
−2.60 to
1.09
−3.30 to
1.50
3 to 10 0 to 8 0 to 8 9 to 26
GDS-15, Geriatric Depression Scale 15-items; M, Mean; SD, Standard deviation; Min, Minimum; Max, maximum.
least one ADL. Supplementary Table 1 shows the participant’s
functional performance in each subscale, while Supplementary
Table 3 shows the frequency of responses by each group, stratified
by depression status, in each specific ADL.
Statistical Analysis
Prior to this study analysis, we carried out a factor analysis
with all neuropsychological measures for data reduction, as
previously reported (de Paula et al., 2013b, 2015a). Principal
axis factoring and oblique rotation were adopted. We extracted
and saved the cognitive factors as standardized (z-Scores)
variables based on non-depressed NA performance. The
procedures produced four distinct cognitive factors (Executive
Functions, Language/Semantic Memory, Episodic Memory, and
Visuospatial Abilities), used as dependent variables in the
multivariate analysis. All the factors showed adequate factor
loadings and internal consistency assessed by the Cronbach’s
Alpha (all >0.800).
For cognitive data we carried out MANOVA analysis to assess
the main effect of group (NA × MCI × AD) and clinically
significant depressive symptoms according to GDS cut-off
(Depressed × Non-Depressed) on each neuropsychological
factor. Age and education were used as covariates as they
are significantly correlated with cognitive performance in
these subjects (Supplementary Table 4). We analyzed the
MANOVA residuals to check if their distribution meet the
analysis assumptions. We reported effect sizes by partial eta-
squared (η2p). Since neither age nor education correlated
with functional measures after controlling for global cognitive
functioning in this sample (Supplementary Table 4), we adopted a
multinomial logistic regression model to compare the frequency
of impairment in each aspect of ADL. Group and depression were
added as fixed factors and chi-square tests were adopted for post-
hoc analysis. Effect sizes for chi-square tests were estimated by the
Cramér’s phi (ϕ). Post-hoc analysis comparisons were corrected
for multiple comparisons.
We performed most of the statistical procedures on the SPSS
20.0. Statistical significance was established at 0.05 (two-tailed).
Power analysis for main effects was done in G-Power software
(Faul et al., 2007). For MANOVA, our sample size (n = 274) has
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Language / Semantic
Memory
Episodic Memory Visuospatial Abilities Executive Functions
NA 0.93 0.76 0.76 0.76
MCI 0.23 -0.10 0.09 0.35
AD 0.11 -0.16 -0.35 -0.36
-1.00
-0.75
-0.50
-0.25
0.00
0.25
0.50
0.75
1.00
1.25
1.50
NA MCI AD
* 
* 
* * 
FIGURE 2 | Differences between the estimated marginal means (with age and education as covariates) on neuropsychological measures of depressed
and non-depressed participants in each of the three groups. When we compared depressed and non-depressed participants in each group, we found
significant differences only in NA participants. In this group, participants with clinically significant symptoms of depression showed lower performance in Executive
Functions (p < 0.001, ηp2 = 0.37), Episodic Memory (p < 0.001, ηp2 = 0.21), Language/Semantic Memory (p < 0.001, η2p = 0.14), and Visuospatial Abilities
(p = 0.001, ηp2 = 0.12). Effect sizes from MCI and AD patients ranged from *p <0.01 to 0.03.
a 99% power to detect a large effect size, 86% power to detect a
moderate effect size and only 17% power to detect a small effect
size. We computed power analysis for logistic regression based in
the effect sizes represented by different odds ratio, as proposed
by Chen et al. (2010): 1.68 (small effect size), 3.47 (medium effect
size), 6.71 (large effect size). Based on our sample size we have
93% power to detect a small effect size and 99% power to detect a
small or large effect size in logistic regression.
RESULTS
Our final sample consisted of 274 participants: 62 NA non-
depressed, 34 NA depressed, 63 MCI non-depressed, 22 MCI
depressed, 66 AD non-depressed and 27 AD depressed. We did
not observe a statistically significant difference in the distribution
of depression according to diagnostic groups (χ2 = 2.05, p =
0.359). Table 2 shows neuropsychological and functional data for
each subgroup. Supplementary Tables 1, 2 shows the scores in
specific neuropsychological tests and functional status in each
ADL. Performance of NA participants were relatively similar to
what is expected for older adults with low formal education,
according to Brazilian normative studies, but lower than what is
expected for young adults (Brucki and Rocha, 2004; Banhato and
Nascimento, 2007; Malloy-Diniz et al., 2007b; Aprahamian et al.,
2009; Moreira et al., 2011; de Paula et al., 2015b).
Since, in previous studies we explored the effect of group
in the neuropsychological and functional measures (de Paula
et al., 2013b, 2014), we focused in the interaction between group
TABLE 3 | Interactions between group (NA × MCI × AD) and depression
(present × absent) in cognitive factors and functional measures.
Cognitive and functional measures Group × Depression
F/χ2 p
Language/Semantic memorya 4.61 0.011
Episodic memorya 12.05 <0.001
Executive functionsa 20.79 0.002
Visuospatial abilitiesa 6.29 <0.001
Self-care ADLb 3.00 0.223
Domestic ADLb 8.31 0.016
Complex ADLb 6.55 0.038
General ADLb 8.84 0.012
NA, Normal aging; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease dementia;
ADL, Activities of Daily Living.
aMANOVA (group × depression) covariating age and education for cognitive factors.
bLogistic regression (group × depression) for functional measures.
and depression in cognitive and functional measures. We found
significant interactions for all measures (Table 3).
For cognitive measures, interactions were significant between
depressed and non-depressed NA participants, and the largest
effect size occurred in executive functions (ηp2 = 0.37), followed
by episodic memory (ηp2 = 0.21), language/semantic memory
(ηp2 = 0.14) and visuospatial abilities (ηp2 = 0.12). However,
in MCI and AD participant depression was not associated with
cognitive performance (non-significant effect sizes ranging from
ηp
2
< 0.01 to ηp2 = 0.03). Differences remained significant after
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TABLE 4 | Main effect of depression in cognitive functions and group
comparison’s after covariating age and education.
Non-depresseda Depresseda p ηp2
NORMAL AGING
Language/Semantic
memory
−0.01 (0.14) −0.94 (0.19) <0.001 0.14
Episodic memory −0.01 (0.09) −0.77 (0.12) <0.001 0.21
Visuospatial abilities −0.05 (0.12) −0.77 (0.16) 0.001 0.12
Executive functions −0.06 (012) −1.52 (0.16) <0.001 0.37
MILD COGNITIVE IMPAIRMENT
Language/Semantic
memory
−0.70 (0.11) −0.92 (0.20) 0.329 0.01
Episodic memory −1.25 (0.08) −1.15 (0.14) 0.561 0.01
Visuospatial abilities −0.82 (0.11) −0.91 (0.20) 0.683 0.01
Executive functions −1.12 (0.12) −1.47 (0.20) 0.140 0.03
ALZHEIMER’S DISEASE DEMENTIA
Language/Semantic
memory
−1.66 (0.14) −1.77 (0.22) 0.682 0.01
Episodic memory −1.81 (0.08) −1.65 (0.13) 0.324 0.01
Visuospatial abilities −1.58 (0.13) −1.22 (0.20) 0.154 0.02
Executive functions −2.35 (0.13) −1.99 (0.20) 0.146 0.02
aEstimated marginal mean (standard error).
multiple comparisons correction. These data is show in Table 4
and Figure 2.
The interaction for group × depression in self-care ADL was
not significant (p = 0.223). For instrumental-domestic activities,
we found a significant difference in the NA group (ϕ = 0.341),
where difficulties were more frequent in depressed (32%) than
non-depressed (6%) participants. The same pattern occurred for
instrumental-complex activities (ϕ = 0.314), where depressed
patients (35%) showed more difficulties than non-depressed
participants (10%). Considering all the 13 activities, a significant
difference also occurred in the NA group (ϕ = 0.333), where
depressed participants were more likely to show impairment in at
least one activity (47%) than non-depressed participants (16%).
However, for both MCI and AD participants, no significant
differences were found on instrumental-domestic, instrumental-
complex, or in the general index of ADL (non-significant effect
sizes ranging fromϕ = 0.004 toϕ = 0.185). Differences remained
significant after multiple comparisons correction. Table 5 and
Figure 3 show these analyses.
DISCUSSION
The present results suggest that the association of depressive
symptoms with cognitive and functional performance is
dependent on the degree of global impairment across the
NA-MCI-AD continuum. The effect of depression on cognitive
functions such as episodic memory, language, executive
functions, and visuospatial abilities, was more intense in the
NA group. Depressive symptoms in subjects with MCI or AD
had no significant effect on cognitive performance, with very
low effect sizes. We found an association between depression
and functional measures only in the NA group, and this effect
5% 6%
10%
16%
3%
32%
35%
47%
0%
20%
40%
60%
80%
100%
Self-Care ADL Domestic ADL Complex ADL General ADL
Normal Aging
Normal Aging Normal Aging
0%
29%
49%
56%
5%
27%
45% 45%
0%
20%
40%
60%
80%
100%
Self-Care ADL Domestic ADL Complex ADL General ADL
Mild Cognitive Impairment
8%
73%
85%
91%
15%
70%
85%
89%
0%
20%
40%
60%
80%
100%
Self-Care ADL Domestic ADL Complex ADL General ADL
Alzheimer's disease dementia
p=0.001 
φ=0.341 
p=0.002 
φ=0.314 
p=0.001 
φ=0.333 
FIGURE 3 | Associations between the frequency deficits in different
types of ADL and the presence of clinically significant symptoms of
depression in each group. We found significant differences in frequency of
impairment (partial or complete) of at least one ADL and the presence of
clinically significant symptoms of depression only in the NA group. Impairment
in instrumental-domestic ADL (p = 0.001, ϕ = 0.341), instrumental-complex
ADL (p = 0.002, ϕ = 0.314), and ADL general (p = 0.001, ϕ = 0.333) were
more frequent in participants with clinically significant depressive Symptoms.
The association between depression and ADL was found in MCI or AD
participants (effect sizes ranged from 0.004 to 0.185).
occurred in instrumental-domestic, instrumental-complex, and
general-ADL. In this sense, our results suggest that depression
not be strongly associated with a worse cognitive and functional
phenotype in patients with MCI or AD.
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TABLE 5 | Frequency of impairment in at least one activity of daily living in each group and group comparison’s (chi-square test) between depressed and
non-depressed participants.
NA MCI AD
Impairmenta ND D ND D ND D
Self-care ADL No 95% 97% 100% 95% 92% 85%
Yes 5% 3% 0% 5% 8% 15%
χ2 = 0.20 χ2 = 2.89 χ2 = 1.15
p = 0.656 p = 0.259 p = 0.284
ϕ = 0.045 ϕ = 0.185 ϕ = 0.024
Domestic ADL No 94% 68% 71% 73% 27% 30%
Yes 6% 32% 29% 27% 73% 70%
χ2 = 11.17 χ2 = 0.01 χ2 = 0.05
p = 0.001 p = 0.907 p = 0.818
ϕ = 0.341 ϕ = 0.013 ϕ = 0.185
Complex ADL No 90% 65% 51% 55% 15% 15%
Yes 10% 35% 49% 45% 85% 85%
χ2 = 9.46 χ2 = 0.09 χ2 = 0.01
p = 0.002 p = 0.762 p = 0.967
ϕ = 0.314 ϕ = 0.033 ϕ = 0.004
General ADL No 84% 53% 44% 55% 9% 11%
Yes 16% 47% 56% 45% 91% 89%
χ2 = 10.64 χ2 = 0.67 χ2 = 0.09
p = 0.001 p = 0.414 p = 0.765
ϕ = 0.333 ϕ = 0.089 ϕ = 0.031
NA, Normal Aging; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease dementia; D, Depressed; ND, Non-Depressed; ADL, Activities of daily living.
aRequires partial need of human help to perform at least one ADL of each group.
The effect of depressive symptoms was more pronounced in
executive function in comparison to the other cognitive domains.
Executive dysfunction impairment is an important feature of
late-life depression and is associated with negative outcomes such
as suicide behavior, development of neuropsychiatric symptoms,
and higher risk of dementia (Moreira et al., 2012; Richard-
Devantoy et al., 2012; Diniz et al., 2013). As the integrity of
the fronto-striatal circuitry and dopaminergic neurotransmission
are main correlates of executive functions, we can hypothesize
that these neurobiological correlates are particularly vulnerable
to the deleterious effects of depression (Fitzgerald et al., 2008;
Malloy-Diniz et al., 2013). In this sense, cognitive interventions,
neuromodulation, psychotherapy, or pharmacological treatment
may restore or reduce the intensity of both cognitive deficits and
psychiatric symptoms (Lenze et al., 2014; Mackin et al., 2014;
Diamond et al., 2015). However, this is a complex relationship,
since improvement of depressive symptoms may not necessarily
lead to remission in cognitive deficits (Nebes et al., 2003; Bhalla
et al., 2006) or improvement in cognitive functioning may not
reduce symptoms of depression (McDermott and Gray, 2012).
Cognitive impairment in depression has been associated to
distinct neurobiological changes. Depression is associated with
the hypothalamic-pituitary-adrenal axis dysfunction, a factor
related to higher secretion of glucocorticoids (Butters et al.,
2008). This mechanism relates to hippocampal atrophy and
may be a neurobiological causal factor to the episodic memory
impairment in depressed subjects (Panza et al., 2010; Naismith
et al., 2012). Another important mechanism with may explain
the current findings is the increase of vascular burden, especially
white matter lesions, found in depressed subjects (Tham et al.,
2011). These lesions may reflect on the overall brain functioning
by ischemia or the disruption of frontostriatal connections,
aspects closely related to the executive functions and processing
speed (Royall et al., 2002). A third pathway relates to amyloid
burden: late-life depression is associated to an increase of
β-amyloid, a factor associated with the severity of cognitive
impairment and overall severity of depression (Piccinni et al.,
2013).
However, similar changes were reported in MCI subjects
and patients with AD (Forlenza et al., 2010; Panza et al.,
2010). Therefore, the presence of these neurobiological
changes in subjects with depressive symptoms and MCI/AD
seems not to confer a synergic or an additive effect on
cognitive performance in older adults. On the other hand,
the emergence of neurodegenerative changes in the MCI/AD
continuum may reduce the impact of depression-related
neurobiological changes on cognitive performance. Additional
studies, including neuroimaging and biological markers, are
necessary to disentangle the mechanisms by which depressive
symptoms moderate cognitive performance in these subjects.
We evaluated the impact of depressive symptoms over a broad
range of ADLs. Depressive symptoms were associated with worse
performance only on instrumental-domestic or instrumental-
complex ADL. This pattern of association might be explained by
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the complex nature of the tasks by itself, which my demand more
pronounced involvement motivation, emotional regulation, and
cognitive control. In addition, the effects of depression in
ADL seems weaker than its impact in cognitive functioning.
Our results are in line with recent reports of the literature
(Reppermund et al., 2011; Park et al., 2013; de Paula et al.,
2015a). Previous studies also showed no significant impact of
depression in ADLs. Methodological differences between studies
may help to explain the effects results, in particular sample
setting (population-based, memory clinic and nursing homes)
and different strategies and scales to assess ADLs (objective
assessment, informant-based assessment; Reppermund et al.,
2011). Given the importance of this topic, additional studies are
necessary to address the impact of late-life depression in the
performance on ADLs.
The present study should be viewed in light of some
limitations, which hinders its generalization to other populations.
First, we used the GDS-15 to evaluate depressive symptoms
and we did not carry out a structured psychiatric interview to
confirm the presence of a depressive episode. Despite the fact
that GDS-15 is widely used in clinical and research settings, there
is criticism about the use of the GDS-15 on the assessment of
depressive symptoms in AD and other dementias. Therefore,
we might have misidentified cases of depression in AD group,
what may have influenced the present results. The cross-sectional
design and the recruitment of participants among individuals
referred to a cognitive evaluation due to memory complaints
also limit the generalization of the present results. On the other
hand, cognitive performance was evaluated by a comprehensive
neuropsychological protocol, which was not used to define
each subject diagnosis. This is a major strength of our study
and reduces the risk of circularity and bias in the present
analyses.
In conclusion, the present study reanalyzed a previously
published dataset and showed a significant association of
depressive symptoms on multiples domains of cognition
only in older subjects with no evidence of global cognitive
impairment. In addition, the effect of depressive symptoms on
functional performance was restricted to domestic and complex
ADLs. Additional studies, with a prospective design and with
population-based samples are necessary to replicate the present
findings.
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